Contents will be Updated soon...

ABSTRACT SUBMISSION GUIDELINES

Abstract Submission

Call for Abstract

Abstract submissions are open exclusively for healthcare professionals working or involved with haemophilia care and inherited bleeding disorders in the Asia-Pacific region.

Important Dates for Abstract Submissions

Last date for abstract submission: 7 July 2025
Abstract Notification of acceptance for oral/poster abstracts: 25 July 2025
Last date for withdrawal of oral/poster Abstract: 1 August 2025
Last Date for Presenting Author registration:(To also align with the general last date of registration) 10 August 2025
Available topics: The content of the abstract must be related to haemophilia and bleeding disorders under the following categories. The submitter can select the appropriate topic for each abstract submitted:
  • Clinical
  • Laboratory
  • Musculoskeletal
  • Multi-disciplinary Care: Nursing, Dental, Psychosocial

General Guidelines

  1. Abstracts must be informative, up to 300 words, excluding the title, author affiliations, and section headings (Aims, Methods, Results & Conclusions).
  2. A maximum of one table or graph in JPG format is allowed.
  3. Abstracts must describe original work at the time of submission. Case reports and case series are also encouraged.
  4. All abstracts are subject to review by the Abstract Review Committee. Acceptance into the program is not guaranteed.
  5. Abstracts must be submitted online. Submissions via email, hard copy, or other modes will not be accepted.
  6. AHAD-AP members and non-members are welcome to submit abstracts.
  7. Abstracts must be submitted in clear English. Abstracts containing spelling, grammar, or scientific mistakes will be rejected. No proofreading will be conducted.
  8. The Abstract Review Committee reserves the right to reject abstracts where inappropriate slicing of results into multiple abstracts is suspected. Duplicate submissions under different topics will be rejected.
  9. The presenting author must register for the Annual Scientific Meeting. Failure to register by the specified date will result in abstract withdrawal.
  10. Submitting an abstract constitutes a formal commitment to present in person if accepted.
  11. Only healthcare professionals involved in haemophilia care haemophilia and inherited bleeding disorders may submit abstracts.

Abstract Format and Submission Details

Abstract Title Write the title in sentence case without quotation marks. (Example: *The results of the research study on ALL in Indonesia.*)
Authors and Affiliations
  • Corresponding/Submitting Author: The submitter will be the primary contact for all correspondence.
  • Presenting Author: Enter details in the provided fields (even if the corresponding author is the same).
  • Co-authors: The system allows up to 10 co-authors. For additional co-authors, contact the conference secretariat.
Abstract Text

The committee suggests the following format:

  • Aims
  • Methods
  • Results
  • Conclusions
  • Key words

For Case Reports/Case Series: Use the headings below:

  • Introduction (for Aims)
  • Details of the case/ cases (for Methods)
  • Discussion (for Results)
  • Conclusion (for Conclusion)

Conflict of Interest Statement

Indicate any commercial company involvement in the research. Use one of the following statements:
  • "No conflict of interest to disclose."
  • "This research was supported by [Company Name]. The company had no role in analysing the data or preparing the abstract."
  • "This research was supported by [Company Name], which [describe the company’s role]."
This statement is mandatory and will appear wherever the abstract is published. For oral presentations, a disclosure slide will be required.

Important Note:

  • If the abstract is not submitted in the prescribed format, it will not be considered for review.
  • The final decision of the abstract review committee will be binding.
  • More than 1 abstract can be submitted by any individual/ author.
  • If an author as the presenting author is not able to present for the conference due to any reason, prior permission must be obtained from the Abstract Review Committee regarding the change in the presenting author.

After Submission

  • The Abstract Review Committee will review all submissions. Each abstract will be evaluated by 3 experts.
  • Abstracts may be selected for oral presentations, poster displays, or rejected.
  • Only the presenting author will be notified of acceptance or rejection.
Criteria Description Weightage
1. Significance of the topic Significant implications for haemophilia care, including new therapies or patient care improvements. 5
2. Clarity of objectives Clearly stated objectives following PICOTS. Congruence of Title, Aim & Conclusions. 15
3. Methodological rigor & Scientific quality Sound design, adequate sample size, statistical power, and well-supported conclusions. 20
4. Originality/ Novelty Original research advancing knowledge in haemophilia. 5
5. Relevance Relevant to the Asia Pacific and its needs. 5

Presentation Formats:

  • The highest quality abstracts will be selected for an oral presentation.
  • Oral Presentation: Presenting authors will receive details of the session date and time. In-person attendance is mandatory.
  • Poster Displays: Presenting authors must attend in person. No virtual presentations are allowed. Poster guidelines will be provided.

Certificates

Oral Presentation:

  • The best oral presentation will be awarded with a "Best Presenter" certificate.
  • All other oral presenters will receive an oral presentation certificate.

Poster Presentation:

Abstracts selected for poster display will receive a participation e-certificate. Note*: Abstracts will not be published in proceedings for AHAD-AP 2025.

Withdrawal Policy

Withdrawals must be notified to AHAD-AP before August 1, 2025.

Support for Abstract Presenters

AHAD-AP offers Travel Grant (additional) for AHAD-AP Member.

TRAVEL GRANT

AHAD-AP offers additional travel grants to the best 100 abstracts selected for either oral or poster.
The additional travel grant is a top up to the existing Travel grants for AHAD-AP members, as outlined here Registration 2025 | AHADAP
Best 20 (Abstract 1-20) Best 80 (Abstract 21-100)
USD 200 USD 100
Only the **original presenting author** who fulfils the following criteria will qualify for this grant. If the original author is changed or the abstract is withdrawn, the award will be forfeited.

Eligibility Criteria:

  1. The applicant must be an active member of AHAD-AP. a. If Ordinary member, must be within 5 years of Highest Qualification. b. Allied Health Professional and Associate Members.
  2. The abstract must be selected by AHAD-AP.
  3. The applicant must be the presenting author of the submitted abstract.
  4. The applicant must register for the meeting by July 31, 2025.
  5. The additional grant will be awarded only once, regardless of the number of abstracts accepted among the top 100 from the same author.

How to apply for the additional Travel Grant?

Tick the appropriate box on the online abstract submission site and verify AHAD-AP membership

Contents will be Updated soon...

ABSTRACT SUBMISSION GUIDELINES

Abstract Submission

Call for Abstract

Abstract submissions are open exclusively for healthcare professionals working or involved with haemophilia care and inherited bleeding disorders in the Asia-Pacific region.

Important Dates for Abstract Submissions

Last date for abstract submission: 7 July 2025
Abstract Notification of acceptance for oral/poster abstracts: 25 July 2025
Last date for withdrawal of oral/poster Abstract: 1 August 2025
Last Date for Presenting Author registration:(To also align with the general last date of registration) 10 August 2025
Available topics: The content of the abstract must be related to haemophilia and bleeding disorders under the following categories. The submitter can select the appropriate topic for each abstract submitted:
  • Clinical
  • Laboratory
  • Musculoskeletal
  • Multi-disciplinary Care: Nursing, Dental, Psychosocial

General Guidelines

  1. Abstracts must be informative, up to 300 words, excluding the title, author affiliations, and section headings (Aims, Methods, Results & Conclusions).
  2. A maximum of one table or graph in JPG format is allowed.
  3. Abstracts must describe original work at the time of submission. Case reports and case series are also encouraged.
  4. All abstracts are subject to review by the Abstract Review Committee. Acceptance into the program is not guaranteed.
  5. Abstracts must be submitted online. Submissions via email, hard copy, or other modes will not be accepted.
  6. AHAD-AP members and non-members are welcome to submit abstracts.
  7. Abstracts must be submitted in clear English. Abstracts containing spelling, grammar, or scientific mistakes will be rejected. No proofreading will be conducted.
  8. The Abstract Review Committee reserves the right to reject abstracts where inappropriate slicing of results into multiple abstracts is suspected. Duplicate submissions under different topics will be rejected.
  9. The presenting author must register for the Annual Scientific Meeting. Failure to register by the specified date will result in abstract withdrawal.
  10. Submitting an abstract constitutes a formal commitment to present in person if accepted.
  11. Only healthcare professionals involved in haemophilia care haemophilia and inherited bleeding disorders may submit abstracts.

Abstract Format and Submission Details

Abstract Title Write the title in sentence case without quotation marks. (Example: *The results of the research study on ALL in Indonesia.*)
Authors and Affiliations
  • Corresponding/Submitting Author: The submitter will be the primary contact for all correspondence.
  • Presenting Author: Enter details in the provided fields (even if the corresponding author is the same).
  • Co-authors: The system allows up to 10 co-authors. For additional co-authors, contact the conference secretariat.
Abstract Text

The committee suggests the following format:

  • Aims
  • Methods
  • Results
  • Conclusions
  • Key words

For Case Reports/Case Series: Use the headings below:

  • Introduction (for Aims)
  • Details of the case/ cases (for Methods)
  • Discussion (for Results)
  • Conclusion (for Conclusion)

Conflict of Interest Statement

Indicate any commercial company involvement in the research. Use one of the following statements:
  • "No conflict of interest to disclose."
  • "This research was supported by [Company Name]. The company had no role in analysing the data or preparing the abstract."
  • "This research was supported by [Company Name], which [describe the company’s role]."
This statement is mandatory and will appear wherever the abstract is published. For oral presentations, a disclosure slide will be required.

Important Note:

  • If the abstract is not submitted in the prescribed format, it will not be considered for review.
  • The final decision of the abstract review committee will be binding.
  • More than 1 abstract can be submitted by any individual/ author.
  • If an author as the presenting author is not able to present for the conference due to any reason, prior permission must be obtained from the Abstract Review Committee regarding the change in the presenting author.

After Submission

  • The Abstract Review Committee will review all submissions. Each abstract will be evaluated by 3 experts.
  • Abstracts may be selected for oral presentations, poster displays, or rejected.
  • Only the presenting author will be notified of acceptance or rejection.
Criteria Description Weightage
1. Significance of the topic Significant implications for haemophilia care, including new therapies or patient care improvements. 5
2. Clarity of objectives Clearly stated objectives following PICOTS. Congruence of Title, Aim & Conclusions. 15
3. Methodological rigor & Scientific quality Sound design, adequate sample size, statistical power, and well-supported conclusions. 20
4. Originality/ Novelty Original research advancing knowledge in haemophilia. 5
5. Relevance Relevant to the Asia Pacific and its needs. 5

Presentation Formats:

  • The highest quality abstracts will be selected for an oral presentation.
  • Oral Presentation: Presenting authors will receive details of the session date and time. In-person attendance is mandatory.
  • Poster Displays: Presenting authors must attend in person. No virtual presentations are allowed. Poster guidelines will be provided.

Certificates

Oral Presentation:

  • The best oral presentation will be awarded with a "Best Presenter" certificate.
  • All other oral presenters will receive an oral presentation certificate.

Poster Presentation:

Abstracts selected for poster display will receive a participation e-certificate. Note*: Abstracts will not be published in proceedings for AHAD-AP 2025.

Withdrawal Policy

Withdrawals must be notified to AHAD-AP before August 1, 2025.

Support for Abstract Presenters

AHAD-AP offers Travel Grant (additional) for AHAD-AP Member.

TRAVEL GRANT

AHAD-AP offers additional travel grants to the best 100 abstracts selected for either oral or poster.
The additional travel grant is a top up to the existing Travel grants for AHAD-AP members, as outlined here Registration 2025 | AHADAP
Best 20 (Abstract 1-20) Best 80 (Abstract 21-100)
USD 200 USD 100
Only the **original presenting author** who fulfils the following criteria will qualify for this grant. If the original author is changed or the abstract is withdrawn, the award will be forfeited.

Eligibility Criteria:

  1. The applicant must be an active member of AHAD-AP. a. If Ordinary member, must be within 5 years of Highest Qualification. b. Allied Health Professional and Associate Members.
  2. The abstract must be selected by AHAD-AP.
  3. The applicant must be the presenting author of the submitted abstract.
  4. The applicant must register for the meeting by July 31, 2025.
  5. The additional grant will be awarded only once, regardless of the number of abstracts accepted among the top 100 from the same author.

How to apply for the additional Travel Grant?

Tick the appropriate box on the online abstract submission site and verify AHAD-AP membership

 


Quick Links

Reach Us

  • Association for Haemophilia and Allied Disorders-Asia Pacific